CareDx, Inc.

CDNA

CareDx, Inc.

CDNA

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-29Shares Purchased (TTM):0Shares Sold (TTM):162,519

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:51,812,399Shares Outstanding:51,151,794Institutional Ownership Pct.:101.29%

Earnings Market Reaction:

Filing Date:2026-04-28Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Medical Laboratories

NTRA DGX LH GH CELC CAI

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	78	65	91	68	89	115	95	96	93	82	76	88
Marketable Securities Current	109	112	103	118	142	146	145	133	123	153	192	195
Accounts Receivable Net Current	45	43	48	67	71	65	67	66	60	51	52	52
Inventory Net	26	27	28	28	23	20	19	19	20	19	18	19
Prepaid Expense And Other Assets Current	11	11	30	26	25	7	7	6	7	8	7	8
Assets Current	269	257	300	307	350	352	334	321	303	314	345	361
Property Plant And Equipment And Finance Lease Rig…	33	33	31	32	33	34	34	34	34	35	35	36
Operating Lease Right Of Use Asset	21	23	24	25	26	24	26	27	29	30	31	32
Marketable Securities Noncurrent	11	24	-	-	-	0	-	-	-	-	-	-
Intangible Assets Net Excluding Goodwill	32	32	33	36	37	38	40	42	43	46	46	44
Goodwill	40	40	40	40	40	40	40	40	40	40	40	40
Restricted Cash And Cash Equivalents Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	3	3	3	3	2	2	2	2	2	1	2	2
Assets	411	413	432	444	490	491	477	467	452	467	501	515
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	10	12	10	8	8	6	6	10	13	9	10
Employee Related Liabilities Current	21	38	23	19	14	38	30	25	15	20	17	14
Litigation Reserve Current	-	-	20	20	20	-	-	-	-	-	-	-
Accrued Liabilities And Other Liabilities	50	42	44	44	43	43	45	47	46	45	47	50
Liabilities Current	79	90	99	93	85	89	81	78	70	78	73	74
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	0
Business Combination Contingent Consideration Liab…	0	0	0	0	0	0	-	-	-	2	-	-
Warrants And Rights Outstanding	-	-	-	-	-	-	-	-	-	0	0	0
Operating Lease Liability Noncurrent	18	20	21	23	24	22	24	25	27	28	29	31
Other Liabilities Noncurrent	0	0	1	1	1	1	97	97	98	97	0	0
Liabilities	98	110	121	117	110	113	204	202	196	205	107	110
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,052	1,044	1,036	1,029	1,023	1,013	985	969	960	947	937	924
Accumulated Other Comprehensive Income Loss Net Of…	-6	-6	-6	-6	-7	-9	-7	-8	-8	-7	-9	-8
Retained Earnings Accumulated Deficit	-733	-735	-719	-695	-637	-626	-704	-697	-695	-678	-534	-510
Stockholders Equity	314	303	311	327	379	378	273	265	256	261	394	405
Liabilities And Stockholders Equity	411	413	432	444	490	491	477	467	452	467	501	515
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	51	51	51	53	55	55	53	53	52	52	54	54
Shares Outstanding	51	51	51	53	55	55	53	53	52	52	54	54

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.28%	19.49%	81.33%	-	-	-	-	-	-	-	-	-
2025	0.41%	12.80%	-29.41%	4.27%	13.97%	14.27%	23.07%	34.16%	40.63%	-7.10%	16.03%	8.18%
2024	17.63%	40.42%	71.88%	57.78%	48.22%	19.96%	7.02%	-8.02%	-2.57%	-12.78%	-20.45%	-20.81%
2023	-5.36%	-1.05%	29.92%	-11.87%	-36.59%	-54.71%	56.08%	89.57%	42.50%	-1.85%	-14.51%	59.47%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.40	2.86	3.03	3.30	4.11	3.94	4.10	4.09	4.32	4.02	4.75	4.84
Quick Ratio	2.93	2.45	2.44	2.72	3.55	3.64	3.78	3.77	3.93	3.67	4.40	4.49
Working Capital	190.24M	167.28M	201.24M	214.12M	264.96M	262.46M	252.65M	242.28M	232.88M	235.64M	272.49M	286.32M
Leverage & Debt
Debt to Equity	0.31	0.36	0.39	0.36	0.29	0.30	0.75	0.76	0.77	0.79	0.27	0.27
Interest Coverage TTM	-1.95	-3.36	5.84	4.12	4.28	3.46	-14.00	-15.06	-16.68	-17.14	-9.44	-10.24
Debt Ratio	0.24	0.27	0.28	0.26	0.23	0.23	0.43	0.43	0.43	0.44	0.21	0.21
Efficiency & Turnover
Asset Turnover TTM	0.92	0.84	0.79	0.75	0.74	0.70	0.64	0.61	0.56	0.56	0.57	0.59
Days Sales Outstanding TTM	51.31	51.53	58.35	71.50	69.35	63.24	69.04	72.36	79.25	76.41	75.00	71.85
Receivables Turnover TTM	7.11	7.08	6.25	5.11	5.26	5.77	5.29	5.04	4.61	4.78	4.87	5.08
Per Share Metrics
Diluted EPS TTM	-0.15	-0.40	1.31	1.07	1.18	1.04	-2.77	-3.06	-3.54	-3.54	-1.67	-1.56
Free Cash Flow Per Share TTM	1.34	0.75	0.77	0.30	0.46	0.72	0.15	-0.33	-0.71	-0.47	-0.18	-0.09
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	84.49%	83.66%	83.39%	82.93%	83.52%	83.34%	82.35%	81.50%	79.65%	79.44%	78.97%	78.32%
Operating Profit Margin TTM	-3.93%	-8.10%	16.66%	13.54%	14.42%	12.21%	-53.15%	-61.03%	-73.28%	-72.55%	-33.60%	-28.58%
Net Profit Margin TTM	-1.98%	-5.62%	19.68%	17.06%	18.85%	17.68%	-46.93%	-53.73%	-66.59%	-67.88%	-30.46%	-27.15%
Growth Metrics
Net Revenue Growth (1Y)	19.17%	13.79%	14.46%	14.72%	25.92%	19.07%	5.26%	-3.95%	-13.93%	-12.89%	-6.74%	-1.76%
Net Income Growth (1Y)	-112.54%	-136.19%	-148.00%	-136.42%	-135.65%	-131.01%	62.17%	90.11%	126.97%	148.37%	21.60%	21.01%
EPS Growth (1Y)	-113.55%	-135.84%	-148.36%	-135.01%	-133.35%	-131.59%	66.08%	96.12%	135.53%	146.32%	20.06%	19.67%
Valuation Metrics
P/E TTM	-108.40	-47.01	10.84	18.25	15.02	19.15	-11.25	-5.08	-2.99	-3.39	-4.19	-5.45
P/B TTM	2.83	3.31	2.45	3.24	2.59	2.99	6.05	3.06	2.14	2.47	0.96	1.13
P/S TTM	2.15	2.64	2.13	3.11	2.83	3.39	5.28	2.73	1.99	2.30	1.28	1.48
Market Cap	888.00M	1.00B	763.46M	1.06B	980.91M	1.13B	1.65B	810.60M	547.42M	645.18M	379.25M	457.69M
Enterprise Value	809.52M	937.96M	671.47M	992.35M	891.61M	1.01B	1.56B	714.23M	453.54M	562.39M	302.69M	369.32M
Calculated Values
Free Cash Flow TTM	68.46M	39.73M	40.25M	16.09M	25.15M	38.05M	7.78M	-17.04M	-36.49M	-25.07M	-9.50M	-4.79M
Net Debt	-78.47M	-65.98M	-91.99M	-68.76M	-89.30M	-115.27M	-95.99M	-96.37M	-93.88M	-82.78M	-76.56M	-88.37M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Hanna, John Walter Jr

Title: President and CEO

Shares: 39,900

Price/Share: $29.24

Value: $1,166,676.00

Shares Owned: 661,959

Relationship: Director,Officer

Ownership: Direct

2026-06-15Sale

Owner: Valantine, Hannah

Title: -

Shares: 12,103

Price/Share: $23.11

Value: $279,700.33

Shares Owned: 36,686

Relationship: Director

Ownership: Direct

2026-06-15Sale

Owner: Hanna, John Walter Jr

Title: President and CEO

Shares: 17,683

Price/Share: $24.03

Value: $424,922.49

Shares Owned: 631,959

Relationship: Director,Officer

Ownership: Direct

2026-06-11Sale

Owner: Hanna, John Walter Jr

Title: President and CEO

Shares: 21,998

Price/Share: $24.02

Value: $528,391.96

Shares Owned: 649,642

Relationship: Director,Officer

Ownership: Direct

2026-06-04Sale

Owner: Hanna, John Walter Jr

Title: President and CEO

Shares: 4,835

Price/Share: $24.00

Value: $116,040.00

Shares Owned: 671,640

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	39,900	29.24	$1,166,676.00	661,959	4
2026-06-15	Valantine, Hannah	Director	-	Direct	Sale	12,103	23.11	$279,700.33	36,686	4
2026-06-15	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	17,683	24.03	$424,922.49	631,959	4
2026-06-11	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	21,998	24.02	$528,391.96	649,642	4
2026-06-04	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	4,835	24.00	$116,040.00	671,640	4
2026-05-15	Torres, Arthur A	Director	-	Direct	Sale	6,484	19.89	$128,966.76	38,665	4
2026-05-05	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	2,688	20.68	$55,587.84	113,924	4
2026-04-16	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	10,282	21.12	$217,155.84	676,475	4
2026-02-03	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	4,441	20.56	$91,306.96	125,364	4
2026-01-22	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	19,280	21.16	$407,964.80	597,405	4
2026-01-15	Hanna, John Walter Jr	Director,Officer	President and CEO	Direct	Sale	10,156	21.05	$213,783.80	616,885	4
2025-12-04	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	7,293	19.45	$141,848.85	97,925	4
2025-11-07	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	2,688	15.52	$41,717.76	105,218	4
2025-08-05	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	2,688	12.79	$34,379.52	112,930	4
2025-07-07	Maag, Peter	Director	-	Direct	Sale	10,000	18.58	$185,800.00	308,846	4
2025-06-18	Valantine, Hannah	Director	-	Direct	Sale	10,570	19.16	$202,521.20	38,994	4
2025-06-17	Maag, Peter	Director	-	Direct	Sale	10,000	19.24	$192,400.00	318,846	4
2025-06-11	Hagstrom, William A	Director	-	Direct	Sale	19,391	19.90	$385,880.90	53,979	4
2025-05-28	Hagstrom, William A	Director	-	Direct	Sale	30,000	17.45	$523,500.00	53,979	4
2025-05-12	Cournoyer, Christine	Director	-	Direct	Sale	29,136	15.96	$465,010.56	37,045	4
2025-05-06	Cournoyer, Christine	Director	-	Direct	Sale	16,700	14.13	$235,971.00	37,045	4
2025-05-05	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	2,688	14.70	$39,513.60	121,350	4
2025-04-30	Maag, Peter	Director	-	Direct	Sale	13,281	17.23	$228,831.63	316,743	4
2025-04-07	Jain, Abhishek	Officer	Chief Financial Officer	Direct	Sale	265	17.72	$4,695.80	337,418	4
2025-04-07	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	924	17.72	$16,373.28	126,911	4
2025-03-10	Bickerstaff, George	Director	-	Direct	Sale	20,000	18.36	$367,200.00	103,027	4
2025-02-04	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	3,512	23.30	$81,829.60	104,677	4
2024-12-04	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	1,917	26.00	$49,842.00	110,237	4
2024-11-26	Maag, Peter	Director	-	Direct	Sale	5,000	25.00	$125,000.00	330,024	4
2024-11-25	Novack, Jeffrey Adam	Officer	Secretary and General Counsel	Direct	Sale	1,223	24.00	$29,352.00	112,154	4
2024-08-21	Johnson, Alexander L	Officer	See Remarks	Direct	Sale	21,557	32.58	$702,327.06	284,983	4
2024-08-20	Maag, Peter	Director	-	Direct	Sale	35,552	33.05	$1,174,993.60	330,024	4
2024-08-19	Johnson, Alexander L	Officer	See Remarks	Direct	Sale	34,231	33.63	$1,151,188.53	284,983	4
2023-10-02	Seeto, Reginald	Director,Officer	See Remarks	Direct	Sale	2,818	6.91	$19,472.38	479,164	4
2023-09-05	Seeto, Reginald	Director,Officer	See Remarks	Direct	Sale	2,819	9.49	$26,752.31	481,982	4
2023-08-14	Seeto, Reginald	Director,Officer	See Remarks	Direct	Sale	576	8.89	$5,120.64	484,801	4
2023-08-02	Seeto, Reginald	Director,Officer	See Remarks	Direct	Sale	2,819	10.96	$30,896.24	486,051	4
2023-07-13	Seeto, Reginald	Director,Officer	See Remarks	Direct	Sale	5,260	10.33	$54,335.80	488,870	4
2023-07-13	Maag, Peter	Director	-	Direct	Sale	5,000	10.34	$51,700.00	309,657	4
2023-07-03	Seeto, Reginald	Director,Officer	See Remarks	Direct	Sale	2,818	8.48	$23,896.64	498,055	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

101.29%

Inst. Shares: 51,812,399

Shares Outstanding: 51,151,794

2025-12-31

96.78%

Inst. Shares: 51,572,758

Shares Outstanding: 53,287,546

2025-09-30

101.01%

Inst. Shares: 53,035,865

Shares Outstanding: 52,507,582

2025-06-30

97.63%

Inst. Shares: 53,018,843

Shares Outstanding: 54,304,754

2025-03-31

98.47%

Inst. Shares: 54,416,289

Shares Outstanding: 55,262,459

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	51,812,399	51,151,794	101.29%
2025-12-31	51,572,758	53,287,546	96.78%
2025-09-30	53,035,865	52,507,582	101.01%
2025-06-30	53,018,843	54,304,754	97.63%
2025-03-31	54,416,289	55,262,459	98.47%
2024-12-31	51,556,551	52,773,247	97.69%
2024-09-30	50,274,851	52,903,338	95.03%
2024-06-30	52,202,471	52,195,620	100.01%
2024-03-31	51,934,230	51,692,358	100.47%
2023-12-31	50,330,219	53,764,705	93.61%
2023-09-30	53,421,193	54,178,759	98.60%
2023-06-30	54,997,738	53,846,260	102.14%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

CareDx, Inc. (CDNA) — SEC Financial Statements & Analysis

CareDx, Inc. (CDNA) is a services-medical laboratories company, incorporated in DE. CareDx, Inc. trades on Nasdaq as: CDNA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CareDx, Inc. reported a 19.17% year-over-year revenue growth, a Gross Profit Margin of 84.49% (TTM), a Debt-to-Equity ratio of 0.31x, a Price-to-Sales (P/S) ratio of 2.15x (TTM), a Price-to-Book (P/B) ratio of 2.83 (TTM), at a market cap of $888.00M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 19.17%
Gross Profit Margin TTM: 84.49%
Debt To Equity: 0.31x
P/S TTM: 2.15x
P/B TTM: 2.83
Market Cap: $888.00M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CareDx, Inc. in?

CareDx, Inc. (CDNA) operates in the Services-Medical Laboratories industry.

What is CDNA's market cap?

CareDx, Inc. (CDNA) has a market capitalization of $888.00M as of 2026-03-31.

What exchange does CDNA trade on?

CareDx, Inc. (CDNA) trades on the Nasdaq.

Where is CareDx, Inc. incorporated?

CareDx, Inc. is incorporated in DE.

CareDx, Inc. (CDNA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.